Cargando…
Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
In 2012, the Food and Drug Administration (FDA) approved the use of F-18 florbetapir to estimate β-amyloid neuritic plaque density when indicated. A normal scan will show increased radiotracer uptake in the white matter. Mild uptake in salivary glands, skin, muscles, and bones is considered normal....
Autores principales: | Itani, Malak, Gunes, Burcak Yilmaz, Akaike, Gensuke, Behnia, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826461/ https://www.ncbi.nlm.nih.gov/pubmed/29487666 http://dx.doi.org/10.1016/j.radcr.2017.10.029 |
Ejemplares similares
-
[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
por: Lilleker, James B, et al.
Publicado: (2019) -
Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment
por: Shokouhi, Sepideh, et al.
Publicado: (2016) -
Calciphylaxis on bone scan: correlation between molecular and cross-sectional findings
por: Itani, Malak, et al.
Publicado: (2016) -
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
por: Weston, Philip S.J., et al.
Publicado: (2015) -
Application of Haralick texture features in brain [(18)F]-florbetapir positron emission tomography without reference region normalization
por: Campbell, Desmond L, et al.
Publicado: (2017)